PARALLEL ADVISORS, LLC Regeneron Pharmaceuticals, Inc. Transaction History

PARALLEL ADVISORS, LLC portfolio value:

$1.18M
portfolio value

PARALLEL ADVISORS, LLC quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.15% -132 shares 89K $688.87 1.71K
Q2 2022 share Increase +74.88% 790 shares 361K $591.13 1.84K
Q1 2022 share Decrease -4.52% -50 shares 32K $698.42 1.05K
Q4 2021 share Increase +6.05% 63 shares 67K $642.51 1.10K
Q3 2021 share Increase +73.38% 441 shares 295K $605.18 1.04K
Q2 2021 share Increase +19.25% 97 shares 98K $558.54 601
Q1 2021 share Decrease -27.69% -193 shares -99K $473.14 504
Q4 2020 share Decrease -21.77% -194 shares -162K $483.11 697
Q3 2020 share Increase +36.03% 236 shares 91K $559.78 891
Q2 2020 share Increase +18.23% 101 shares 138K $623.65 655
Q1 2020 share Increase +57.83% 203 shares 138K $488.29 554
Q4 2019 share Increase +26.26% 73 shares 55K $375.48 351
Q3 2019 share Decrease -15.76% -52 shares -26K $277.4 278
Q2 2019 share Decrease -16.46% -65 shares -59K $313 330
Q1 2019 share Increase +6.76% 25 shares 24K $410.62 395
Q4 2018 share Decrease -21.11% -99 shares -51K $373.5 370
Q3 2018 share Increase +15.52% 63 shares 49K $404.04 469
Q2 2018 share Decrease -12.31% -57 shares -19K $344.99 406
Q1 2018 share Decrease -7.58% -38 shares -29K $344.36 463
Q4 2017 share Decrease -19.97% -125 shares -58K $375.96 501
Q3 2017 share Decrease -3.84% -25 shares -74K $447.12 626
Q2 2017 share Decrease -40.06% -435 shares -122K $491.14 651
Q1 2017 share Increase +5.74% 59 shares 65K $387.51 1.08K
Q4 2016 share Increase 0.00% 1.02K shares 377K $367.09 1.02K